Lipids have been of major interest and importance in fi eld of drug delivery systems. Their application in formulation science has been diverse and promising in different ways. The number of reports published each year on lipid based formulations and lipid based formulations in market establish critical role of lipids in drug delivery. Of considerable importance is the application of lipids in design of particulate systems which are amenable to surface modifi cations for improved drug/gene delivery. In the past few years, reports on different lipid based particulate systems have increased tremendously with major focus on liposomes and solid lipid nanoparticles (SLNs) [ 1 -7 ]. Other lipid based particulate systems that are evaluated include nanostructured lipid carriers (NLCs) [ 6 , 8 -11 ], emulsions [ 12 -17 ], lipid-drug conjugates (LDCs) and recently reported lipid nano-particulates in the form of LeciPlex [ 18 , 19 ], and polymer-lipid hybrid nanoparticles (PLN) [ 20 -22 ]. One of the various reasons responsible for success of lipids in formulation of particulate systems is their bio-compatible and biodegradable nature [ 2 , 19 , 23 ]. Thus, lipid based particulate systems can suitably be employed for delivery through not only noninvasive routes, such as oral and topical, but also through parenteral routes which are very demanding with reference to delivery system design.Lipid particulate systems, over the years, have undergone stupendous modifi cations. Initially lipid particulate system of micron size were reported which were followed by lipid particulates in nanosize range. The nanosize range of particles made them capable of targeting tumors better, primarily because of enhanced